Citation Safe vs. Casetext / CoCounsel

Casetext built genuine goodwill among solo and small-firm lawyers as an accessible, well-priced alternative to Westlaw and Lexis. Thomson Reuters' 2023 acquisition and subsequent shutdown of the standalone product in April 2025 removed that specific option from the market. Its capabilities live on inside CoCounsel Legal, but reporting indicates the successor is priced meaningfully higher — roughly three times the original Casetext's per-seat cost — and is now positioned within the broader Westlaw Advantage bundle rather than sold as an accessible standalone product.

If you were a Casetext subscriber specifically because it was an affordable alternative to a full Westlaw or Lexis contract, CoCounsel Legal via Westlaw Advantage is a different value proposition — a premium product for firms already committed to, or moving toward, the Westlaw ecosystem, not a standalone budget option. Citation Safe does not attempt to replace Casetext's broad research capability. What we offer instead is a narrower, purpose-built, self-serve verification layer priced specifically for the solo and small-firm budget the original Casetext also served.

If your research needs were served by Casetext's AI-assisted case law search and drafting, you'll need a different tool for that specific job — whether CoCounsel Legal at its current price, a competing AI research platform, or manual research through a free resource like CourtListener. Whatever you choose for research, a separate, independent citation verification pass before filing remains worthwhile: reported hallucination rates for AI research tools generally, even sophisticated ones, are not at zero.

Casetext's shutdown is a useful reminder that legal AI products, even well-loved ones, can disappear or be repriced entirely at an acquirer's discretion. This is one more argument for building your verification workflow around a specific, well-defined problem — citation accuracy — rather than around any single vendor's broader platform, since a narrower tool is generally easier to replace if a vendor changes course, shuts down, or moves upmarket the way Casetext's technology effectively did after acquisition.

We can't promise Citation Safe will never change its pricing or product direction — no vendor honestly can make that promise, and Casetext's story is a good reason to be skeptical of any that do. What we can point to is a business model built around a narrow, well-defined, self-serve product for a specific underserved buyer (solo and small-firm lawyers), rather than a venture-backed platform play likely to get acquired and repriced upmarket the way Casetext was. That's a structural reason for optimism about accessibility, not a guarantee.

For lawyers who built their research habits around Casetext's specific interface and workflow over several years, the transition to CoCounsel Legal's different packaging and pricing is a real, disruptive change worth planning for rather than assuming it's a seamless continuation. If you're currently navigating that transition, it's a reasonable moment to also evaluate your citation verification process more broadly, since you're already reassessing your research tool stack.

Casetext's shutdown removed an accessible research option from the market; Citation Safe doesn't replace that research capability, but fills the accessible, self-serve verification gap the shutdown left behind.